From Aqua Cure to next-generation gene therapies, Umbrella Corporation's global pharmaceutical R&D demands precision at molecular scale. Uncountable's AI-powered platform accelerates drug compound optimization, viral vector formulation, and bioprocess scale-up across every division and facility worldwide.
From the Arklay Research Complex to European and Asia-Pacific divisions, Umbrella operates pharmaceutical and biotech R&D facilities across multiple continents. Manual workflows, fragmented data, and disconnected systems can't keep pace with next-generation therapeutic development.
Engineering novel viral compounds requires optimizing thousands of variables simultaneously — host compatibility, mutagenic stability, capsid composition, and purification parameters across iterative development cycles.
R&D teams across the Arklay Complex, Raccoon City NEST facility, European labs, and Asia-Pacific divisions generate fragmented datasets. Critical findings remain locked in local systems, invisible to the broader organization.
Pharmaceutical formulation involves complex ingredient interactions, stability profiles, and bioavailability trade-offs that overwhelm traditional Design of Experiments approaches.
Tracking specimens, cell lines, viral stocks, and experimental lots across programs like the Tyrant Series and Nemesis Project demands rigorous chain-of-custody documentation at every stage.
Moving formulations from laboratory bench to manufacturing scale introduces new variables — batch size, equipment differences, environmental controls — that require systematic re-optimization.
FDA, EMA, and government contracts require complete audit trails for every formulation decision. Compartmentalized access across clearance levels adds further complexity to documentation workflows.
Replace fragmented spreadsheets and disconnected lab notebooks with a unified, AI-powered system of record for all of Umbrella Corporation's pharmaceutical and biotech R&D.
From viral vector engineering to pharmaceutical formulation, Uncountable accelerates every research workflow across Umbrella Corporation's global pipeline.
Optimize viral compound stability, host compatibility, and mutagenic properties across iterative development cycles. AI-driven DoE explores the vast design space with 45% fewer physical experiments.
AI DoE Bayesian Optimization Surface ModelingAccelerate drug formulation development by predicting stability, bioavailability, and dissolution profiles before running physical tests. Optimize excipient ratios and coating formulations with ML models.
Predictive Models Cost OptimizationDesign optimal growth media for mammalian cell lines, microbial fermentation, and bioreactor conditions. The UBCS division relies on systematic formulation of countermeasure agents and stabilization compounds.
Formulation Management Correlation AnalysisTransition formulations from laboratory bench to pilot plant to GMP manufacturing. Systematically re-optimize process parameters as batch size, equipment, and environmental conditions change.
Scale-Up Ingredient ReplacementOptimize adjuvant formulations, antigen stability, and delivery systems. Track thousands of experimental conditions across multi-stage clinical development with full traceability.
AI DoE Experiment TrackingAccelerate long-term research programs spanning decades of iterative compound development. Leverage historical formulation data to predict outcomes, guide the next experiment, and avoid repeating past failures.
Visualization TraceabilityOrganizations like Umbrella Corporation use Uncountable to accelerate R&D, reduce wasted experiments, and bring life-critical formulations to market faster.
AGC Chemicals used Uncountable to centralize formulation data across international R&D teams, accelerating compound development for advanced materials including ETFE films and specialty fluoropolymers.
→ Weeks of experiment time savedSCG Chemicals replaced manual data workflows and custom Python scripts with Uncountable's no-code modeling tools, dramatically accelerating compound resin development across their polyethylene and polypropylene lines.
→ 45% fewer experiments neededNot a generic lab notebook. Not a spreadsheet with a database behind it. Uncountable is purpose-built for organizations that formulate at the molecular level.
Structured, searchable experiment records that connect formulations to outcomes. Every data point is analysis-ready from the moment it's entered.
Manage lab requests, track samples, and connect quality control data directly to your formulation pipeline. Full lot-level traceability from specimen to result.
No-code Bayesian optimization, predictive modeling, and AI-powered data analysis. Your scientists drive the AI — no data science team required.
Scatter plots, surface models, ternary plots, radar charts, and more. One click from raw data to publication-ready insights.
Connect to SAP, ERP, LIMS, lab instruments, and data lakes via REST API, Python SDK, or SFTP. Fits your existing infrastructure.
SAML SSO, SCIM provisioning, role-based access controls, full audit logging, and data encrypted at rest and in transit. Built for pharmaceutical compliance.
See how Uncountable can power Umbrella Corporation's pharmaceutical and biotech R&D — from Aqua Cure to cutting-edge gene therapies, with fewer experiments and faster time to market.